Identifying such a ligand of GPR84 and APMAP may lead to the identification of a novel pathway regulating macrophage function and facilitate the development of novel therapeutics targeting this pathway in addition to GPR84 activators to enhance cancer cell phagocytosis. Here, APMAP is linked to cancer.